25 XP   0   0   10

Idogen AB
Buy, Hold or Sell?

Let's analyse Idogen together

PenkeI guess you are interested in Idogen AB. Buy, hold or sell? I don't know! However, I do recommend doing research before doing anything. I will help you with that.

I'm going to help you getting a better view of Idogen AB. At the end you don't have to ask anyone for trading advice. You can make your own decision, with more confidence, the odds in your favor, backed by data.

You can find me behind Let's Analyse Together in the top-right of each section.

Get notifications about Idogen AB

I send you an email if I find something interesting about Idogen AB.

Quick analysis of Idogen (30 sec.)










What can you expect buying and holding a share of Idogen? (30 sec.)

How much money do you get?

How much money do you get?
kr0.00
When do you have the money?
1 year
How often do you get paid?
0.0%

What is your share worth?

Current worth
kr0.03
Expected worth in 1 year
kr-0.25
How sure are you?
66.7%

+ What do you gain per year?

Total Gains per Share
kr-0.28
Return On Investment
-234.6%

For what price can you sell your share?

Current Price per Share
kr0.12
Expected price per share
kr0.1205 - kr0.1205
How sure are you?
50%

1. Valuation of Idogen (5 min.)




Live pricePrice per Share (EOD)

kr0.12

Intrinsic Value Per Share

kr-4.84 - kr-5.19

Total Value Per Share

kr-4.81 - kr-5.16

2. Growth of Idogen (5 min.)




Is Idogen growing?

Current yearPrevious yearGrowGrow %
How rich?$331.9k$1m-$677.7k-204.2%

How much money is Idogen making?

Current yearPrevious yearGrowGrow %
Making money-$4.3m-$3.5m-$804.3k-18.4%
Net Profit Margin0.0%0.0%--

How much money comes from the company's main activities?

3. Financial Health of Idogen (5 min.)




What can you expect buying and holding a share of Idogen? (5 min.)

Welcome investor! Idogen's management wants to use your money to grow the business. In return you get a share of Idogen.

What can you expect buying and holding a share of Idogen?

First you should know what it really means to hold a share of Idogen. And how you can make/lose money.

Speculation

The Price per Share of Idogen is kr0.1205. The market price reflects what other people think it is worth; not what it's really worth. Your job is to find out if the market price is fair, overpriced, or underpriced. I will help you with that.

If you buy blind, there is a 50% chance of making or losing money by selling the stock in the future. However, we can look at a few things to determine the odds in our favor:

  • The fundamentals: the financial health trends of Idogen.
  • The technials: based on market psychology, we can make a calculated estimate of what the price will do in the future. We can do this through technical analysis. We can calculate the probabilities and the expected value (millionaire math). That's called speculation.
  • The book value: what is the market price compared to it's book value.

Investing

If you really want to invest in Idogen, you will have to let go of the thought of selling in the future. If you have to sell the share for less than you bought it, it can still be a good investment. Focus on what it means to hold the stock forever:

  • You own a part of the company. The equity of this part can grow or shrink. The current Book Value per Share is kr0.03. Based on the TTM, the Book Value Change Per Share is kr-0.07 per quarter. Based on the YOY, the Book Value Change Per Share is kr-0.28 per quarter.
  • You may receive quarterly/yearly dividend in the form of additional shares.
  • You may receive quarterly/yearly dividend in the form of cash. Based on the TTM the Dividend per Share is kr0.00 per quarter.
Based on historical numbers we can estimate the returns while holding a share of Idogen.

How much money are you going to get?

 MRQTTMYOY5Y10Y
 kr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Sharekr% of Price per Share
Usd Eps-0.04-34.9%-0.04-34.9%-0.03-28.4%-0.03-25.4%-0.02-17.8%
Usd Book Value Change Per Share-0.01-5.4%-0.01-5.4%-0.03-21.7%-0.01-5.3%0.000.3%
Usd Dividend Per Share0.000.0%0.000.0%0.000.0%0.000.0%0.000.0%
Usd Total Gains Per Share-0.01-5.4%-0.01-5.4%-0.03-21.7%-0.01-5.3%0.000.3%
Usd Price Per Share0.02-0.02-0.12-0.08-0.05-
Price to Earnings Ratio-0.38--0.38--3.55--3.16--1.76-
Price-to-Total Gains Ratio-2.48--2.48--4.66-2.38-2.38-
Price to Book Ratio5.06-5.06-12.56-5.09-2.83-
Price-to-Total Gains Ratio-2.48--2.48--4.66-2.38-2.38-

When do you get the money?

Usd Investment
$.00
Usd Price Per Share0.01107395
Number of shares90302
Gains per QuarterTrailing 12 Months5 Year
Usd Dividend Per Share0.000.00
Usd Book Value Change Per Share-0.01-0.01
Usd Total Gains Per Share-0.01-0.01
Gains per Quarter (90302 shares)-586.38-576.86
Gains per Year (90302 shares)-2,345.54-2,307.43
YearsReturn on Investment (TTM)Return on Investment (5Y)
 DividendBook Value gainTotal gainsDividendBook Value gainTotal gains
Broker costs---10---10
10-2346-23560-2307-2317
20-4691-47020-4615-4624
30-7037-70480-6922-6931
40-9382-93940-9230-9238
50-11728-117400-11537-11545
60-14073-140860-13845-13852
70-16419-164320-16152-16159
80-18764-187780-18459-18466
90-21110-211240-20767-20773
100-23455-234700-23074-23080

How sure are you?

Based on the past periods, how sure are you to get value out of your investment.

Linear %
 Trailing 12 Months3Y5 Year10 YearALLTIME
  % % % % %
Earnings Per Share0.01.00.00.0%0.03.00.00.0%0.05.00.00.0%0.09.00.00.0%0.09.00.00.0%
Book Value Change Per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%6.03.00.066.7%6.03.00.066.7%
Dividend per Share0.00.01.00.0%0.00.03.00.0%0.00.05.00.0%0.00.09.00.0%0.00.09.00.0%
Total Gains per Share0.01.00.00.0%1.02.00.033.3%2.03.00.040.0%6.03.00.066.7%6.03.00.066.7%

Fundamentals of Idogen

About Idogen AB

Idogen AB (publ), a biotechnology company, develops tolerogenic cell therapies to prevent the patient's immune system from attacking biological agents, transplanted organs, and the body's own cells or tissues in Sweden. The company's advanced product candidate is IDO 8 that is designed for patients with severe haemophilia A, who have developed neutralizing antibodies against critical treatment with coagulation factor VIII. It also develops IDO T, a tolerogenic cell therapy to prevent organ transplant rejection primarily kidney transplantation; and IDO AID for the treatment of autoimmune diseases. The company was incorporated in 2008 and is headquartered in Lund, Sweden.

Fundamental data was last updated by Penke on 2024-04-22 08:04:04.

Financial Health

Profitability Details
 Compared to previous yearCompared to industry
Using its assets, the company is very inefficient in making profit.
Using its investors money, the company is very inefficient in making profit.
Operating Efficiency Details
 Compared to previous yearCompared to industry
Liquidity Details
 Compared to previous yearCompared to industry
The company is able to pay all its short-term debts.
The company is able to pay all its short-term debts with the most liquid assets.
Solvency Details
 Compared to previous yearCompared to industry
The company is able to pay all its debts by selling its assets.
The company is able to pay all its debts with equity.

Valuation

Valuation Details
 Compared to previous yearCompared to industry
Based on the equity, the company is overpriced.
Based on the earnings, the company is expensive.
Based on how much money comes from the company's main activities, the company is expensive.

1.1. Profitability of Idogen AB.

1.1. Profitability
1.1.1. Net Profit Margin

Measures how much net profit Idogen earns for each kr1 of revenue.

  • Above 10% is considered healthy but always compare Idogen to the Biotechnology & Medical Research industry mean.
  • A Net Profit Margin of 0.0% means that kr0.00 for each kr1 in revenue is generated as profit.

Let's take a look of the Net Profit Margin trends of Idogen AB:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
1.1.2. Return on Assets

Shows how efficient Idogen is using its assets to generate profit.

  • Above 5% is considered healthy but always compare Idogen to the Biotechnology & Medical Research industry mean.
  • -529.2% Return on Assets means that Idogen generated kr-5.29 profit for each $1 in assets.

Let's take a look of the Return on Assets trends of Idogen AB:

  • The MRQ is -529.2%. Using its assets, the company is very inefficient in making profit. -2
  • The TTM is -529.2%. Using its assets, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-529.2%TTM-529.2%0.0%
TTM-529.2%YOY-168.4%-360.8%
TTM-529.2%5Y-178.8%-350.5%
5Y-178.8%10Y-125.0%-53.8%
1.1.3. Return on Equity

Shows how efficient Idogen is using its investors money to generate profit.

  • Above 15%-20% is considered healthy but always compare Idogen to the Biotechnology & Medical Research industry mean.
  • -1,318.1% Return on Equity means Idogen generated kr-13.18 for each kr1 the owners (shareholders) invested.

Let's take a look of the Return on Equity trends of Idogen AB:

  • The MRQ is -1,318.1%. Using its investors money, the company is very inefficient in making profit. -2
  • The TTM is -1,318.1%. Using its investors money, the company is very inefficient in making profit. -2
Trends
Current periodCompared to+/- 
MRQ-1,318.1%TTM-1,318.1%0.0%
TTM-1,318.1%YOY-353.7%-964.4%
TTM-1,318.1%5Y-394.1%-924.0%
5Y-394.1%10Y-247.5%-146.6%

1.2. Operating Efficiency of Idogen AB.

1.2. Operating Efficiency
1.2.1. Operating Margin

Measures how efficient Idogen is operating .

  • Measures how much profit Idogen makes for each kr1 of sales after paying variable costs (production costs, wages, etc) but before taxes.
  • Above 15% is considered healthy but always compare Idogen to the Biotechnology & Medical Research industry mean.
  • An Operating Margin of 0.0% means the company generated kr0.00  for each kr1 in revenue (before taxes).

Let's take a look of the Operating Margin trends of Idogen AB:

  • The MRQ is 0.0%. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.0%
TTM-YOY-0.0%
TTM-5Y-0.0%
5Y-10Y-0.0%
1.2.2. Operating Ratio

Measures how efficient Idogen is keeping operating costs low.

  • Below 1 is considered healthy (always compare to Biotechnology & Medical Research industry mean).
  • An Operation Ratio of 0.00 means that the operating costs are kr0.00 for each kr1 in net sales.

Let's take a look of the Operating Ratio trends of Idogen AB:

  • The MRQ is 0.000. The data is not here.
Trends
Current periodCompared to+/- 
MRQ-TTM-0.000
TTM-YOY-0.000
TTM-5Y-0.000
5Y-10Y-0.000

1.3. Liquidity of Idogen AB.

1.3. Liquidity
1.3.1. Current Ratio

Measures if Idogen is able to pay off Short-term Debt.

  • Above 1.5 is considered healthy (always compare to Biotechnology & Medical Research industry mean).
  • A Current Ratio of 1.67 means the company has kr1.67 in assets for each kr1 in short-term debts.

Let's take a look of the Current Ratio trends of Idogen AB:

  • The MRQ is 1.671. The company is able to pay all its short-term debts. +1
  • The TTM is 1.671. The company is able to pay all its short-term debts. +1
Trends
Current periodCompared to+/- 
MRQ1.671TTM1.6710.000
TTM1.671YOY1.809-0.138
TTM1.6715Y2.690-1.020
5Y2.69010Y5.410-2.719
1.3.2. Quick Ratio

Measures if Idogen is able to pay off Short-term Debt but only using the most liquid assets.

  • Above 1 is considered healthy but always compare Idogen to the Biotechnology & Medical Research industry mean.
  • A Quick Ratio of 1.48 means the company can pay off kr1.48 for each kr1 in debt (using most liquid assets).

Let's take a look of the Quick Ratio trends of Idogen AB:

  • The MRQ is 1.482. The company is able to pay all its short-term debts with the most liquid assets. +1
  • The TTM is 1.482. The company is able to pay all its short-term debts with the most liquid assets. +1
Trends
Current periodCompared to+/- 
MRQ1.482TTM1.4820.000
TTM1.482YOY1.393+0.089
TTM1.4825Y2.536-1.054
5Y2.53610Y5.195-2.659

1.4. Solvency of Idogen AB.

1.3. Liquidity
1.4.1. Debt to Asset Ratio

Measures how much % of Idogen assets are financed with debt.

  • Below 1 (100%) is considered healthy but always compare Idogen to Biotechnology & Medical Research industry mean.
  • A Debt to Asset Ratio of 0.60 means that Idogen assets are financed with 59.8% credit (debt) and the remaining percentage (100% - 59.8%) is financed by its owners/shareholders. 

Let's take a look of the Debt to Asset Ratio trends of Idogen AB:

  • The MRQ is 0.598. The company is able to pay all its debts by selling its assets. +1
  • The TTM is 0.598. The company is able to pay all its debts by selling its assets. +1
Trends
Current periodCompared to+/- 
MRQ0.598TTM0.5980.000
TTM0.598YOY0.524+0.075
TTM0.5985Y0.405+0.194
5Y0.40510Y0.271+0.134
1.4.2. Debt to Equity Ratio

Measures if Idogen is able to pay off its debts by using shareholders equity.

  • Below 2 is considered healthy but always compare Idogen to the Biotechnology & Medical Research industry mean.
  • A Debt to Equity ratio of 149.1% means that company has kr1.49 debt for each kr1 in shareholders equity.

Let's take a look of the Debt to Equity Ratio trends of Idogen AB:

  • The MRQ is 1.491. The company is able to pay all its debts with equity. +1
  • The TTM is 1.491. The company is able to pay all its debts with equity. +1
Trends
Current periodCompared to+/- 
MRQ1.491TTM1.4910.000
TTM1.491YOY1.100+0.391
TTM1.4915Y0.790+0.701
5Y0.79010Y0.490+0.300

2. Market Valuation of Idogen AB

2.1. Earnings Per Share
2.1. Price to Earnings Ratio

Measures how much money you pay for each share for every kr1 in earnings Idogen generates.

  • Above 15 is considered overpriced but always compare Idogen to the Biotechnology & Medical Research industry mean.
  • A PE ratio of -0.38 means the investor is paying kr-0.38 for every kr1 in earnings.

Let's take a look of the Price to Earnings Ratio trends of Idogen AB:

  • The EOD is -0.263. Based on the earnings, the company is expensive. -2
  • The MRQ is -0.383. Based on the earnings, the company is expensive. -2
  • The TTM is -0.383. Based on the earnings, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.263MRQ-0.383+0.119
MRQ-0.383TTM-0.3830.000
TTM-0.383YOY-3.551+3.169
TTM-0.3835Y-3.160+2.778
5Y-3.16010Y-1.756-1.405
2.2. Price To Free Cash Flow Ratio

Let's take a look of the Price To Free Cash Flow Ratio trends of Idogen AB:

  • The EOD is -0.240. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The MRQ is -0.349. Based on how much money comes from the company's main activities, the company is expensive. -2
  • The TTM is -0.349. Based on how much money comes from the company's main activities, the company is expensive. -2
Trends
Current periodCompared to+/- 
EOD-0.240MRQ-0.349+0.109
MRQ-0.349TTM-0.3490.000
TTM-0.349YOY-3.390+3.041
TTM-0.3495Y-3.015+2.666
5Y-3.01510Y-1.675-1.340
2. Book Value per Share
2.3. Price to Book Ratio

Measures if the stock price of Idogen is to cheap or to expensive compared to its book value.

  • At or below 1 is considered healthy (always compare to Biotechnology & Medical Research industry mean).
  • A PB ratio of 5.06 means the investor is paying kr5.06 for each kr1 in book value.

Let's take a look of the Price to Book Ratio trends of Idogen AB:

  • The EOD is 3.482. Based on the equity, the company is fair priced.
  • The MRQ is 5.057. Based on the equity, the company is overpriced. -1
  • The TTM is 5.057. Based on the equity, the company is overpriced. -1
Trends
Current periodCompared to+/- 
EOD3.482MRQ5.057-1.575
MRQ5.057TTM5.0570.000
TTM5.057YOY12.559-7.502
TTM5.0575Y5.090-0.034
5Y5.09010Y2.828+2.262
2. Total Gains per Share

3. Summary

3.1. Key Performance Indicators

The key performance indicators of Idogen AB compared to the Most Recent Quarter (MRQ).

 End of day+/-Most Recent QuarterTrailing 12 Months+/-Year-Over-Year+/-5 Year+/-10 Year+/-
Book Value Change Per Share---0.071-0.0710%-0.284+302%-0.070-2%0.004-1938%
Book Value Per Share--0.0350.0350%0.105-67%0.239-86%0.212-84%
Current Ratio--1.6711.6710%1.809-8%2.690-38%5.410-69%
Debt To Asset Ratio--0.5980.5980%0.524+14%0.405+48%0.271+121%
Debt To Equity Ratio--1.4911.4910%1.100+36%0.790+89%0.490+204%
Dividend Per Share----0%-0%-0%-0%
Eps---0.457-0.4570%-0.372-19%-0.333-27%-0.233-49%
Free Cash Flow Per Share---0.501-0.5010%-0.390-22%-0.327-35%-0.233-54%
Free Cash Flow To Equity Per Share---0.115-0.1150%-0.302+163%0.030-480%0.056-304%
Gross Profit Margin--1.0001.0000%1.0000%1.0000%1.0000%
Intrinsic Value_10Y_max---5.190--------
Intrinsic Value_10Y_min---4.842--------
Intrinsic Value_1Y_max---0.370--------
Intrinsic Value_1Y_min---0.416--------
Intrinsic Value_3Y_max---1.225--------
Intrinsic Value_3Y_min---1.317--------
Intrinsic Value_5Y_max---2.219--------
Intrinsic Value_5Y_min---2.285--------
Market Cap12577067.000-45%18265450.00018265450.0000%137982428.000-87%94917715.600-81%52732064.222-65%
Net Profit Margin----0%-0%-0%-0%
Operating Margin----0%-0%-0%-0%
Operating Ratio----0%-0%-0%-0%
Pb Ratio3.482-45%5.0575.0570%12.559-60%5.090-1%2.828+79%
Pe Ratio-0.263+31%-0.383-0.3830%-3.551+828%-3.160+726%-1.756+359%
Price Per Share0.121-45%0.1750.1750%1.322-87%0.909-81%0.505-65%
Price To Free Cash Flow Ratio-0.240+31%-0.349-0.3490%-3.390+872%-3.015+764%-1.675+380%
Price To Total Gains Ratio-1.705+31%-2.477-2.4770%-4.656+88%2.382-204%2.382-204%
Quick Ratio--1.4821.4820%1.393+6%2.536-42%5.195-71%
Return On Assets---5.292-5.2920%-1.684-68%-1.788-66%-1.250-76%
Return On Equity---13.181-13.1810%-3.537-73%-3.941-70%-2.475-81%
Total Gains Per Share---0.071-0.0710%-0.284+302%-0.070-2%0.004-1938%
Usd Book Value--331942.800331942.8000%1009705.300-67%2289621.799-86%2028710.084-84%
Usd Book Value Change Per Share---0.006-0.0060%-0.026+302%-0.006-2%0.000-1938%
Usd Book Value Per Share--0.0030.0030%0.010-67%0.022-86%0.019-84%
Usd Dividend Per Share----0%-0%-0%-0%
Usd Eps---0.042-0.0420%-0.034-19%-0.031-27%-0.021-49%
Usd Free Cash Flow---4810321.700-4810321.7000%-3740330.000-22%-3139824.797-35%-2235610.844-54%
Usd Free Cash Flow Per Share---0.046-0.0460%-0.036-22%-0.030-35%-0.021-54%
Usd Free Cash Flow To Equity Per Share---0.011-0.0110%-0.028+163%0.003-480%0.005-304%
Usd Market Cap1155832.457-45%1678594.8551678594.8550%12680585.133-87%8722938.064-81%4846076.702-65%
Usd Price Per Share0.011-45%0.0160.0160%0.121-87%0.084-81%0.046-65%
Usd Profit---4375175.200-4375175.2000%-3570866.400-18%-3191065.388-27%-2237746.120-49%
Usd Revenue----0%-0%-0%-0%
Usd Total Gains Per Share---0.006-0.0060%-0.026+302%-0.006-2%0.000-1938%
 EOD+3 -5MRQTTM+0 -0YOY+10 -195Y+2 -2710Y+1 -28

3.2. Fundamental Score

Let's check the fundamental score of Idogen AB based on Penke's default stock scanner.

Penke's Stock Scanner

  
  
IndicatorConditionValue
Price to Earnings Ratio (EOD)Between0-15-0.263
Price to Book Ratio (EOD)Between0-13.482
Net Profit Margin (MRQ)Greater than00.000
Operating Margin (MRQ)Greater than00.000
Quick Ratio (MRQ)Greater than11.482
Current Ratio (MRQ)Greater than11.671
Debt to Asset Ratio (MRQ)Less than10.598
Debt to Equity Ratio (MRQ)Less than11.491
Return on Equity (MRQ)Greater than0.15-13.181
Return on Assets (MRQ)Greater than0.05-5.292
Total3/10 (30.0%)

3.3. Technical Score

Let's check the technical score of Idogen AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.000
Ma 20Greater thanMa 500.121
Ma 50Greater thanMa 1000.121
Ma 100Greater thanMa 2000.121
OpenGreater thanClose0.121
Total0/5 (0.0%)



Latest Balance Sheet

Balance Sheet of 2022-12-31. Currency in SEK. All numbers in thousands.

Summary
Total Assets8,996
Total Liabilities5,384
Total Stockholder Equity3,612
 As reported
Total Liabilities 5,384
Total Stockholder Equity+ 3,612
Total Assets = 8,996

Assets

Total Assets8,996
Total Current Assets8,995
Long-term Assets1
Total Current Assets
Cash And Cash Equivalents 5,304
Net Receivables 2,674
Total Current Assets  (as reported)8,995
Total Current Assets  (calculated)7,978
+/- 1,017
Long-term Assets
Property Plant Equipment 1,505
Intangible Assets 1
Long-term Assets  (as reported)1
Long-term Assets  (calculated)1,506
+/- 1,505

Liabilities & Shareholders' Equity

Total Current Liabilities5,384
Long-term Liabilities2,105
Total Stockholder Equity3,612
Total Current Liabilities
Accounts payable 2,105
Other Current Liabilities 3,279
Total Current Liabilities  (as reported)5,384
Total Current Liabilities  (calculated)5,384
+/-0
Long-term Liabilities
Long-term Liabilities  (as reported)2,105
Long-term Liabilities  (calculated)0
+/- 2,105
Total Stockholder Equity
Common Stock5,102
Retained Earnings -47,750
Other Stockholders Equity 46,260
Total Stockholder Equity (as reported)3,612
Total Stockholder Equity (calculated)3,612
+/-0
Other
Capital Stock5,102
Cash and Short Term Investments 5,304
Common Stock Shares Outstanding 62,729
Liabilities and Stockholders Equity 8,996
Net Debt -5,304
Net Invested Capital 3,612
Net Tangible Assets 3,612
Net Working Capital 3,611



Balance Sheet

Currency in SEK. All numbers in thousands.

 Trend2022-12-312021-12-312020-12-312019-12-312018-12-312017-12-312016-12-312015-12-312014-12-31
> Total Assets 
3,970
13,279
20,668
44,187
71,674
31,189
50,843
23,069
8,996
8,99623,06950,84331,18971,67444,18720,66813,2793,970
   > Total Current Assets 
3,264
12,137
18,866
38,193
62,957
27,745
48,723
21,858
8,995
8,99521,85848,72327,74562,95738,19318,86612,1373,264
       Cash And Cash Equivalents 
3,036
11,542
18,502
36,943
61,605
26,008
47,041
15,560
5,304
5,30415,56047,04126,00861,60536,94318,50211,5423,036
       Net Receivables 
0
0
219
752
706
867
975
1,266
2,674
2,6741,26697586770675221900
       Other Current Assets 
227
594
363
1,250
1,353
0
1,682
1
0
011,68201,3531,250363594227
   > Long-term Assets 
706
1,142
1,803
5,993
8,716
3,444
2,119
1,211
1
11,2112,1193,4448,7165,9931,8031,142706
       Property Plant Equipment 
0
0
0
2,764
4,656
3,444
2,120
1,211
1,505
1,5051,2112,1203,4444,6562,764000
       Intangible Assets 
706
1,142
1,803
3,230
4,060
0
0
0
1
10004,0603,2301,8031,142706
       Other Assets 
0
0
0
0
0
0
1
-1
0
0-11000000
> Total Liabilities 
516
1,111
2,072
4,299
20,651
12,860
10,222
12,082
5,384
5,38412,08210,22212,86020,6514,2992,0721,111516
   > Total Current Liabilities 
516
1,111
2,072
4,299
20,651
12,860
10,222
12,083
5,384
5,38412,08310,22212,86020,6514,2992,0721,111516
       Accounts payable 
66
389
996
3,343
7,167
2,184
1,588
1,924
2,105
2,1051,9241,5882,1847,1673,34399638966
       Other Current Liabilities 
450
722
1,076
956
13,484
10,677
8,634
10,159
3,279
3,27910,1598,63410,67713,4849561,076722450
   > Long-term Liabilities 
0
0
0
0
0
2,184
1,588
-1
2,105
2,105-11,5882,18400000
> Total Stockholder Equity
3,453
12,168
18,597
39,888
51,023
18,329
40,621
10,987
3,612
3,61210,98740,62118,32951,02339,88818,59712,1683,453
   Common Stock
194
685
856
1,454
3,394
3,394
12,770
16,149
5,102
5,10216,14912,7703,3943,3941,454856685194
   Retained Earnings 
-2,007
-11,665
-1,777
-5,669
7,882
-21,894
-48,716
-87,570
-47,750
-47,750-87,570-48,716-21,8947,882-5,669-1,777-11,665-2,007
   Capital Surplus 000000000
   Treasury Stock000000000
   Other Stockholders Equity 
5,266
23,148
19,518
44,102
39,747
36,829
76,567
82,408
46,260
46,26082,40876,56736,82939,74744,10219,51823,1485,266



Balance Sheet

Currency in SEK. All numbers in thousands.




Cash Flow

Currency in SEK. All numbers in thousands.




Income Statement

Currency in SEK. All numbers in thousands.


Latest Income Statement (annual, 2022-12-31)

Gross Profit (+$)
totalRevenue0
Cost of Revenue-0
Gross Profit00
 
Operating Income (+$)
Gross Profit0
Operating Expense-47,474
Operating Income-47,972-47,474
 
Operating Expense (+$)
Research Development0
Selling General Administrative34,857
Selling And Marketing Expenses0
Operating Expense47,47434,857
 
Net Interest Income (+$)
Interest Income0
Interest Expense-1
Other Finance Cost-0
Net Interest Income-1
 
Pretax Income (+$)
Operating Income-47,972
Net Interest Income-1
Other Non-Operating Income Expenses0
Income Before Tax (EBT)-47,111-48,833
EBIT - interestExpense = -47,973
-47,111
-47,607
Interest Expense1
Earnings Before Interest and Taxes (EBIT)-47,972-47,110
Earnings Before Interest and Taxes (EBITDA)-46,255
 
After tax Income (+$)
Income Before Tax-47,111
Tax Provision-0
Net Income From Continuing Ops-47,111-47,111
Net Income-47,608
Net Income Applicable To Common Shares-47,750
 
Non-recurring Events
Discontinued Operations0
Extraordinary Items0
Effect of Accounting Charges0
Other Items0
Non Recurring0
Other Operating Expenses47,474
Total Other Income/Expenses Net8611
 

Technical Analysis of Idogen
The psychology behind the price

Technical indicators reflecting market sentiment and the collective psychology of you and other traders. Your emotions and other traders' emotions, such as fear and greed, play a significant role in driving price movements.

General trend

First of all, I'm going to put something in the back of your mind. One of the most stable factors that gives you more confidence as a trader: the general trend of Idogen. The general trend of Idogen is BEARISH with 100.0% confidence. It is very important for your mental being to use each indicator with this in mind. But beware, also the general trend flips once in a while! You can use moving averages to determine Idogen's overall trend. For convenience I use the most commonly used moving averages: 20, 50, 100 & 200. Of course you can use other moving averages or other indicators to determine the trend.

Indicator phases

Some of the indicators I use have 3 zones: overbought, oversold and neutral. Transitions between these zones (market phases) provide valuable trading signals and insights. Expecially with the general trend mind, I use the highlighted phases:

Indicator zone transitionsBullish trend (-100.0%) Bearish trend (100.0%)
Overbought to neutralBullish pullback=Bearish reversal
Upper to lower neutralBullish correction=Bearish continuation
Nuetral to oversoldOversold=Oversold
Oversold to neutralBullish reversal=Bearish correction
Lower to upper neutralBullish continuation=Bearish pullback
Nuetral to overboughtOverbought=Overbought

1. Price Targets

1.1 Support & Resistance

Support and resistance are levels on a price chart that act as barriers or zones where the price of an asset tends to stop, reverse, or experience a significant amount of buying or selling pressure.

Support is a price level at which demand for an asset is strong enough to prevent the price from falling further.
Resistance is a price level at which selling pressure becomes significant enough to prevent the price of an asset from rising further.


Score

Let's take a look at the Support & Resistance of Idogen AB.

The long score for the Support & Resistance is 1/1.
The longshort score for the Support & Resistance is 1/(-1 +1).

  • Around support: The price is currently trading around a support level. This can be considered as a potential entry level. +1

The bullish price targets are: 0.1205 < 0.1205 < 0.1205.

The bearish price targets are: 0.1205 > 0.1205 > 0.1205.

Tweet this
Idogen AB Daily Support & Resistance Chart

2. Trend Indicators

2.1 Moving Averages

Shows the moving average of the selected period.

  • Moving averages are lagging trend indicators.
  • There are many types of moving averages.
  • Moving averages are also used within other indicators.

Score

Let's take a look at the Moving Averages of Idogen AB. The current mas is .

The long score for the Moving Averages is 0/14.
The longshort score for the Moving Averages is -14/(-14 +14).

  • MA 20 trending down: The MA 20 is trending down. -1
  • Close < MA 20: The price is below the MA 20. -1
  • MA 20 < MA 50: The MA 20 is lower than the MA 50. -1
  • MA 20 < MA 100: The MA 20 is lower than the MA 100. -1
  • MA 20 < MA 200: The MA 20 is lower than the MA 200. -1
  • MA 50 trending down: The MA 50 is trending down. -1
  • Close < MA 50: The price is below the MA 50. -1
  • MA 50 < MA 100: The MA 50 is lower than the MA 100. -1
  • MA 50 < MA 200: The MA 50 is lower than the MA 200. -1
  • MA 100 trending down: The MA 100 is trending down. -1
  • Close < MA 100: The price is below the MA 100. -1
  • MA 100 < MA 200: The MA 100 is lower than the MA 200. -1
  • MA 200 trending down: The MA 200 is trending down. -1
  • Close < MA 200: The price is below the MA 200. -1

Directionalities and relatives.

Moving AverageAmount of candlesTrendPrice +/-vs. MA 50vs. MA 100vs. MA 200
MA 2020
MA 5050-
MA 100100--
MA 200200---

Explanation: https://www.youtube.com/watch?v=xwW8h0lrQ-I

Idogen AB Daily Moving Averages Chart
2.2 Moving Average Convergence/Divergence (MACD)

Shows the momentum of the selected period based on two moving averages.

  • MACD is a lagging momentum indicator.
  • Uses two moving averages.
  • Can show buy or sell signals based on momentum.
  • Can show overbought. and oversold. levels.

Score

Let's take a look at the Moving Average Convergence/Divergence (MACD) of Idogen AB. The current macd is 0.

The long score for the Moving Average Convergence/Divergence (MACD) is 0/4.
The longshort score for the Moving Average Convergence/Divergence (MACD) is -4/(-4 +4).

  • MACD line < signal line: The MACD line is below the signal line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Idogen price going down in the near term. -2
  • MACD < 0: The MACD is below the zero line (centerline), it indicates a bearish signal for Idogen. This means that the short-term moving average is lower than the long-term moving average, signaling negative momentum and suggesting a higher likelihood of the Idogen price continuing to fall in the near future. It indicates that sellers are gaining control, and there is negativism in the market, leading to potential price decreases. -1
  • Trending down: The MACD line is trending down. This indicates that the short-term moving average is falling faster than the long-term moving average, suggesting negative momentum in the market. This signals that sellers are becoming more active and insecure, leading to potential price decreases as traders anticipate further losses and are willing to sell at lower prices. -1
Idogen AB Daily Moving Average Convergence/Divergence (MACD) ChartIdogen AB Daily Moving Average Convergence/Divergence (MACD) Chart
2.3 Directional Movement Index (DMI)

The DMI is a collection of 3 indicators: +DI (Plus Direction Indicator), -DI (Minus Direction Indicator) and ADX (Average Directional Index). The ADX helps you determine the strength of a trend.


Score

Let's take a look at the Directional Movement Index (DMI) of Idogen AB. The current adx is 17.58.

The long score for the Directional Movement Index (DMI) is 1/7.
The longshort score for the Directional Movement Index (DMI) is 1/(-7 +7).

  • PLUS_ID > MINUS_DI: The +DI line is above the -DI line. This indicates a bullish signal in the market, as the positive directional movement is currently stronger than the negative directional movement, showing that buyers have the upper hand. Market psychology suggests that traders are optimistic, expecting further price increases, and are more willing to buy Idogen shares, leading to potential upward momentum in its price. +1
  • PLUS_ID > MINUS_DI && ADX < 25 && ADX trending down: The ADX is below 25 and indicates a weak or no trend. Also, the ADX is declining so there is no trend indication.
Idogen AB Daily Directional Movement Index (DMI) Chart
2.4 Parabolic SAR

Shows the current trend and potential entry and exit signals.

  • Parabolic SAR (stop and reverse) is a lagging trend indicator.
  • Shows the current trend.
  • Shows potential entry signals.
  • Shows  potential exit signals.
  • Can be used to place trailing stoplosses..

Score

Let's take a look at the Parabolic SAR of Idogen AB. The current sar is 0.11942295.

The long score for the Parabolic SAR is 1/1.
The longshort score for the Parabolic SAR is 1/(-1 +1).

  • Close > SAR: The price is above the SAR. It's generally considered a bullish signal. +1
Idogen AB Daily Parabolic SAR Chart

3. Momentum Indicators

3.1 Relative Strength Index (RSI)

Measures the speed and change of price movements.

  • Leading momentum indicator, meaning the signals are instant.
  • Ranges between 0 and 100.
  • Above 70 is considered overbought.
  • Below 30 is considered oversold.
  • Above or below 50 can also be used to determine price trend or support and resistance.
  • RSI divergence looks at a deviation between RSI and price movement. Penketrading automatically calculates RSI divergences.
  • Can be used in many different ways

Score

Let's take a look at the Relative Strength Index (RSI) of Idogen AB. The current rsi is 0. The current phase is Oversold in bear market.

The long score for the Relative Strength Index (RSI) is 1/13.
The longshort score for the Relative Strength Index (RSI) is 1/(-13 +13).

  • Oversold in bear market: Short-term excessive selling, potential for relief rally. Be cautious, consider taking short-term long positions. +1
Idogen AB Daily Relative Strength Index (RSI) ChartIdogen AB Daily Relative Strength Index (RSI) Chart
3.2 Stochastic Oscillator

Compares a certain price to multiple prices ranging over time.

  • Leading momentum indicator, meaning the signals are instant.
  • Used to determine overbought and oversold areas much like the RSI.
  • Ranges between 0 and 100.
  • Above 80 is considered overbought.
  • Below 20 is considered oversold.
  • Consists of two lines named K and D.
  • K compares the highest high and lowest low on the selected price range.
  • The D line is a moving average of the K line.
  • Can be used to spot divergences

Score

Let's take a look at the Stochastic Oscillator of Idogen AB. The current phase is Oversold in bear market.

The long score for the Stochastic Oscillator is 0/6.
The longshort score for the Stochastic Oscillator is -6/(-6 +6).

  • STOCH < 50: The STOCH %K is below 50. There are more sellers than buyers. -1
  • STOCH < 20: The STOCH %K is below 20 and oversold. -2
  • STOCH %K line < STOCH %D line: The STOCH %K line is below the STOCH %D line, which indicates a bearish signal in the market. This means that the negative momentum is currently stronger than the average momentum, suggesting that sellers are more active than buyers, and there's a higher probability of the Idogen price going down in the near term. -2
  • Trending down: The STOCH %K is trending down. -1
Idogen AB Daily Stochastic Oscillator ChartIdogen AB Daily Stochastic Oscillator Chart
3.3 Commodity Channel Index (CCI)

Measures the difference between the current price and the historical average price.

  • Lagging or leading Momentum indicator
  • When the CCI is above zero, the price is above the historical average
  • When the CCI is below zero, the price is below the historical average
  • Used for spotting trends
    • If the CCI moves from negative or near zero to positive 100 that might indicate an uptrend
    • If the CCI moves from positive or near zero to negative -100 that might indicate a downtrend

Score

Let's take a look at the Commodity Channel Index (CCI) of Idogen AB. The current cci is -66.66666667.

Idogen AB Daily Commodity Channel Index (CCI) ChartIdogen AB Daily Commodity Channel Index (CCI) Chart
3.4 Chande Momentum Oscillator (CMO)

Measures the difference between the sum of recent gains and the sum of recent losses. Then divides the result by the sum of all price movements in that period.

  • Lagging momentum indicator
  • Ranges between +100 and -100
  • Considered overbought above +50
  • Considered oversold below -50
  • It's possible to add a moving average that acts as a signal line

Score

Let's take a look at the Chande Momentum Oscillator (CMO) of Idogen AB. The current cmo is 0.

Idogen AB Daily Chande Momentum Oscillator (CMO) ChartIdogen AB Daily Chande Momentum Oscillator (CMO) Chart
3.5 Williams %R

 Shows the current price relative to the highest high over the last 14 days.
 

  • Lagging momentum indicator
  • Ranging between 0 and -100
  • Above -20 is considered overbought
  • Below -80 is considered oversold
  • Is prone to give false signals

Score

Let's take a look at the Williams %R of Idogen AB. The current willr is 0.

The long score for the Williams %R is 1/1.
The longshort score for the Williams %R is 1/(-1 +1).

  • WILLR > -20: The Williams %R is above -20. This indicates that the price is in overbought territory, suggesting a potential price correction or trend reversal to the downside. +1
Idogen AB Daily Williams %R ChartIdogen AB Daily Williams %R Chart

4. Volatility Indicators

4.1 Bollinger Bands

Shows if the price is to high or to low relative to an average.

  • Lagging volatility indicator
  • Uses 3 bands: one upper, one lower and one in the middle
  • Works best when the middle band reflects an intermediate trend (MA20).
  • When the price is moving closer to the upper band, the market might be overbought
  • When the price is moving closer to the lower band, the market might be oversold 

Score

Let's take a look at the Bollinger Bands of Idogen AB.

Idogen AB Daily Bollinger Bands Chart
4.2 Average True Range (ATR)
Measures market volatility
  • Leading volatility indicator
  • Can be used to determine stop-loss positions
  • Calculated by:
    • Current high minus the current low
    • Current high minus the previous close
    • Current low minus the previous close
  • The larger the range of the candles, the greater the ATR value

Score

Let's take a look at the Average True Range (ATR) of Idogen AB. The current atr is 0.0000.

Idogen AB Daily Average True Range (ATR) ChartIdogen AB Daily Average True Range (ATR) Chart

5. Volume Indicators

5.1 On-Balance Volume (OBV)

 Measures market volatility

  • Leading momentum indicator
  • Calculation:
    • If the closing price is above the previous closing price: OBV = previous OBV + current volume
    • If the closing price is below the previous closing price: OBV = previous OBV - current volume
    • If the closing price is the same as the previous closing price than the OBV is the same.
  • Can be used to confirm price trends
  • Can be used with divergences

Score

Let's take a look at the On-Balance Volume (OBV) of Idogen AB. The current obv is -26,489,336.

Idogen AB Daily On-Balance Volume (OBV) ChartIdogen AB Daily On-Balance Volume (OBV) Chart
5.2 Money Flow Index (MFI)

Measures the flow of money in and out of a security

  • Lagging momentum indicator
  • Looks like RSI but uses volume as an extra metric (RSI only considers price)
  • Above 80 is considered overbought
  • Below 20 is considered oversold
  • Can be used with divergences

Score

Let's take a look at the Money Flow Index (MFI) of Idogen AB. The current mfi is 0.

The long score for the Money Flow Index (MFI) is 0/2.
The longshort score for the Money Flow Index (MFI) is -2/(-2 +2).

  • MFI < 50: -1
  • MFI < 20: -1
Idogen AB Daily Money Flow Index (MFI) ChartIdogen AB Daily Money Flow Index (MFI) Chart

6. Summary

6.1. Notifications

TypeNotificationDate
PenkeCurrently no notifications for Idogen AB.

6.2. Trading Signals

Below you will find trading signals as the indicator is commonly used. This doesn't mean you should use it that way. Learn from these, but don't use them blindly. I recommend using at least 4 indicators, 1 from each category: trend, momentum, volatility and volume.

DateIndicatorSignal
2024-03-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-03-13MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.
2024-04-05MACD SHORT ENTRY LONG CLOSEThe MACD line crosses below the signal line.

6.3. Candlestick Patterns

Idogen AB Daily Candlestick Chart
DateCandlestick Pattern

6.4. Technical Score

Let's check the technical score of Idogen AB based on Penke's default Symbol scanner.

Penke's Symbol Scanner

  
  
IndicatorConditionValue
RsiGreater than500.000
Ma 20Greater thanMa 500.121
Ma 50Greater thanMa 1000.121
Ma 100Greater thanMa 2000.121
OpenGreater thanClose0.121
Total0/5 (0.0%)
Penke

Good job! You gained 25 XP and 0   0   10 . What's next:

  • Share my analysis of Idogen with someone you think should read this too:
  • Are you bullish or bearish on Idogen? Let me know what you think in the comments.
  • Do you want an email if I find something interesting about Idogen? Add an email alert using the form below.
  • Join the community if you want to keep your earnings and track your progress: Join the community
  • Is this analysis useful to you? Support me via But Me a Coffee. I'll analyze the stock market faster for you!

Get notifications about Idogen AB

I send you an email if I find something interesting about Idogen AB.


Comments

How you think about this?

Leave a comment

Stay informed about Idogen AB.

Receive notifications about Idogen AB in your mailbox!